DATA SCIENCE TO EMPOWER
LIFE SCIENCE INNOVATION

From the discovery of safe and effective targets to the identification of most promising drug candidates, we accelerate drug development by leveraging our state-of-the-art AI/ML powered discovery engine, coupled with our deep domain expertise in pharmacology and medicinal chemistry.

We integrate a systems biomedicine perspective with our advanced computational biomarker discovery platform to decipher disease & drive beneficial therapeutic innovations across indications. Founded on our holistic drug-disease-target understanding, we empower the cost-effective repurposing of drugs that have been shelved, failed, in-development, or even approved, towards novel indications.

Wielding advanced AI/ML and deep learning algorithms, we empower indication prioritization, patient stratification, and drug combination prediction, to personalize and maximize treatment benefits for all cancer patients. Our pharmacology modeling and simulation services further help optimize dosing, clinical trial design, and predict clinical outcomes, enabling new therapeutics to advance efficiently through clinical testing.

Excelra’s GOSTAR is the world’s largest structure-activity-relationship database that houses comprehensive intelligence on bio-active compounds in discovery, development, and market. Meticulously curated by hundreds of scientists from a plethora of public sources, GOSTAR facilitates rapid target validation, virtual screening, and lead optimization to accelerate drug development.

Explore our end-to-end customized chemistry content management and data curation solutions.

Excelra’s GOBIOM is the world’s largest repository of disease biomarkers, carefully curated from a vast array of sources in exploratory, preclinical and clinical domains. GOBIOM is an essential biomarker toolkit for drug development, aiding in target identification, safety/toxicity profiling, patient stratification, and clinical outcome prediction.

Explore our custom curation and content management services encompassing big data from pan-omics and multiscale systems biology.

Excelra’s IOClinica is an Immuno-Oncology focused clinical trial intelligence application that provides comprehensive, up-to-date, actionable insights into biomarker, combination strategies, clinical trial design, and competitive intelligence. Our proprietary Clinical Trial Outcome Database (CTOD) is an exhaustive and synoptic compilation of published clinical trial outcomes across more than 90 therapeutic areas; which enables rational trial design and Go/No-Go decisions. We also provide custom curation services across preclinical toxicity reports, clinical trial protocols and outcomes.